Prostate cancer screening: facts, statistics, and interpretation in response to the US Preventive Services Task Force Review

J Clin Oncol. 2012 Jul 20;30(21):2581-4. doi: 10.1200/JCO.2011.40.4327. Epub 2012 Jun 18.
No abstract available

MeSH terms

  • Advisory Committees
  • Age Factors
  • Aged
  • Biomarkers, Tumor / blood*
  • Clinical Trials as Topic
  • Data Interpretation, Statistical
  • Early Detection of Cancer / standards*
  • Humans
  • Male
  • Meta-Analysis as Topic
  • Models, Statistical
  • Primary Prevention / standards
  • Primary Prevention / trends
  • Prostate-Specific Antigen / blood*
  • Prostatectomy
  • Prostatic Neoplasms / diagnosis*
  • Prostatic Neoplasms / immunology
  • Prostatic Neoplasms / mortality
  • Prostatic Neoplasms / prevention & control*
  • Referral and Consultation
  • Risk Factors
  • Time Factors
  • United States
  • Watchful Waiting / standards*
  • Watchful Waiting / trends*

Substances

  • Biomarkers, Tumor
  • Prostate-Specific Antigen